This bill aims to eliminate the requirement for prior authorization when prescribing certain interchangeable drugs. Specifically, it states that a carrier, which includes various health insurance entities, cannot require prior authorization if the brand name drug or its generic version is unavailable. Prior authorization is defined as the process used by carriers to assess the medical necessity of a covered service.

The bill is designed to streamline access to necessary medications by removing barriers that may delay treatment when specific drugs are not available. It emphasizes the importance of ensuring that patients can receive interchangeable drugs without the added step of prior authorization, thereby facilitating timely access to essential healthcare services. The act is set to take effect immediately upon passage.